MYRIAD GENETICS, INC. Accounts Receivable, Allowance for Credit Loss, Current
MYRIAD GENETICS, INC. (MYGN) had Accounts Receivable, Allowance for Credit Loss, Current of $12.10 million as of 2018-06-30, per its 10-K filed 2018-08-24.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2018-08-24
- 2018-06-30: Accounts Receivable, Allowance for Credit Loss, Current $12.10M.
- 2018-03-31: Accounts Receivable, Allowance for Credit Loss, Current $10.30M.
- 2017-12-31: Accounts Receivable, Allowance for Credit Loss, Current $9.50M.
- 2017-09-30: Accounts Receivable, Allowance for Credit Loss, Current $8.60M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2018-06-30 | $12.10M 10-K · filed 2018-08-24 | |
| 2018-03-31 | $10.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $9.50M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $8.60M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $7.60M 10-K · filed 2018-08-24 | $8.20M 10-K · filed 2017-08-09 |
| 2017-03-31 | $8.10M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $7.80M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $6.80M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $6.80M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $6.50M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $6.20M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $6.20M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $7.60M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $7.73M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $7.93M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $8.38M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $9.00M 10-K · filed 2015-08-12 | $8.97M 10-K · filed 2014-08-13 |
| 2014-03-31 | $9.75M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $9.20M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $8.90M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $7.50M 10-K · filed 2014-08-13 | |
| 2013-03-31 | $6.30M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $5.30M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $5.00M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $4.60M 10-K · filed 2013-08-14 | |
| 2012-03-31 | $4.30M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $4.00M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $3.70M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $3.70M 10-K · filed 2012-08-15 | |
| 2011-03-31 | $4.20M 10-Q · filed 2011-05-04 | |
| 2010-12-31 | $4.20M 10-Q · filed 2011-02-01 | |
| 2010-09-30 | $4.20M 10-Q · filed 2010-11-03 | |
| 2010-06-30 | $4.40M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |